Tezepelumab helps severe asthma patients reduce oral steroid

Tezepelumab reduces oral steroid dependence in severe asthma patients

Tezepelumab, a new asthma drug, helps patients with severe asthma reduce their dependence on oral steroids while keeping their condition under control. This matters because long-term oral steroid use carries serious side effects like weakened bones and increased infection risk. The finding offers severe asthma patients a potentially safer treatment option.